Call Our Free Legal Helpline Anytime

or call

4 August 2015

Xarelto Lawsuit Plaintiffs Call for Closer Patient Monitoring

Plaintiffs in some of the hundreds of Xarelto lawsuits that have been filed to date are urging for closer patient monitoring as a measure to help prevent serious blood thinner complications such as uncontrolled bleeding and even death.

Anti-coagulant drugs carry inherent health risks, but Xarelto is unique in that it does not have an antidote, nor is there any way to treat patients who are experiencing uncontrolled bleeding as a complication of this anti-coagulant drug.

Coumadin, also known as Warfarin, is regarded as the tried and true blood thinner which was the standard anti-coagulant treatment for many years before new generation blood thinners like Xarelto and Pradaxa became available. Some patients have transitioned to new generation anti-coagulants like Xarelto because it does not typically require frequent blood testing as is the standard with warfarin.

In fact, Xarelto marketing materials touted the fact that the medication does not require regular blood tests and diet monitoring as is required with Warfarin/Coumadin. But plaintiffs who’ve suffered uncontrolled bleeding and other Xarelto complications that led to lawsuits are now saying that Xarelto patients should be more closely monitored and subject to more intensive oversight as a standard course of treatment.

What’s more, many patients claim that they were never informed of the fact that there is no Xarelto antidote, nor is there any emergency treatment available. It’s this lack of a safety net that has MDL plaintiffs pushing for more stringent regulations.

Xarelto Lawsuits Moving Forward

As of mid-July 2015, there were over 800 Xarelto lawsuits filed as part of a multi-district litigation case (MDL No. 2592) that is moving forward in the U.S. District Court for the Eastern District of Louisiana under Judge Eldon E. Fallon. The current number of MDL cases – 805 to be precise – reflects an increase of precisely 253 cases in just one month.

Bellwether trials — trials that evaluate the viability of a case that’s similar to many others in a MDL case — are slated to begin in approximately one year, in August 2016.

The defendants in this Xarelto MDL case include parent company Johnson & Johnson, along with Bayer Healthcare Pharmaceuticals and Janssen Research and Development.

Do You Have a Xarelto Lawsuit?

If you or a loved one suffered uncontrolled bleeding and Xarelto complications, you may have a legal right to financial compensation to cover the costs of your medical treatment and care, along with financial losses from lost wages, funeral expenses, and even pain and suffering.

Hundreds of Xarelto cases have already been filed, but the statute of limitations limits how long you have to file a claim. Don’t miss out on your chance to receive justice and the financial compensation that you and your family members deserve.

Contact The Meldofsky Firm to arrange for a free, confidential case consultation. Call our experienced legal team today by calling 877-274-8672.

You may be eligible for financial compensation.

Name is required.
Email is required.
Phone is required.
Medical condition required.